CHEMICAL TECHNOLOGY

DISCOVER WHAT’S POSSIBLE

February 2, 2022

DISCOVER
AIP Publishing exists to connect authors and readers to a living legacy of published science, accelerate discovery, and advance the physical sciences.

Spotlight

Blade Therapeutics

Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease. Fibrosis, a pathologic process in which progressive scarring replaces functional tissue, drives the progression of several debilitating diseases. Uncontrolled, progressive fibrosis leads to organ dysfunction and failure, and potentially death. In the U.S., many millions of Americans are afflicted with a fibrosis-related disease, which may affect organs including the kidney, liver, lungs, skin, and eye. Blade has assembled scientific and leadership teams with unparalleled experience. Our scientific team as well as our Board have extensive expertise in fibrosis and the discovery and development of anti-fibrotic drugs. Blade’s scientific advisory board includes world renowned experts in the pathobiology of fibrotic disease.

OTHER WHITEPAPERS
news image

Assumptions to the Annual Energy Outlook 2022

whitePaper | March 12, 2022

The National Energy Modeling System (NEMS) Industrial Demand Module (IDM) estimates U.S. energy consumption by energy source (fuels and feedstocks) in the Annual Energy Outlook (AEO) for 15 manufacturing and 6 nonmanufacturing industries.

Read More
news image

Optimising chemistry performance through heterogeneous catalyst design

whitePaper | December 5, 2022

Chemical catalysis by platinum group metal (PGM) based materials is an essential synthetic technology for the fine chemical industry. Catalysis enables the acceleration of the reaction rate using a substance that itself is not consumed.

Read More
news image

Unlock The World’s Largest Carbon Market

whitePaper | May 14, 2022

When we tout the progress that human civilization has achieved in the past few centuries, we must recognize the costs that come with it. Among these, the cost of climate change.

Read More
news image

THE ROLE OF AI IN THE CHEMICAL MANUFACTURING INDUSTRY

whitePaper | November 15, 2019

The parts of the world that lack robust chemical manufacturing sectors are nevertheless intimately linked to the chemical industry. They depend mightily on a variety of imported goods provided by chemical producers: plastics, fuel, lubricants, fertilizer, pesticides and much more. Disruptions in the industry, leading to shortages or price hikes, pose a major threat to the economy and wellbeing of many communities throughout the world.

Read More
news image

NEW LIFE FOR RECYCLED PLASTIC: CHARACTERIZINGPOSTCONSUMER RESIN WITH MATERIALS ANALYSIS

whitePaper | August 21, 2022

It’s impossible to think about plastics without picturing piles of soda bottles, filmy food wrappers, and other packaging floating in the ocean or washing up on the shore.

Read More
news image

Optimizing Carbon Capture, Utilization and Storage to Meet Ambitious Sustainability Goals

whitePaper | October 5, 2022

The race to a zero carbon future is on. Global oil and gas, petrochemical and chemical companies alike have announced ambitious and broad carbon mitigation.

Read More

Spotlight

Blade Therapeutics

Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease. Fibrosis, a pathologic process in which progressive scarring replaces functional tissue, drives the progression of several debilitating diseases. Uncontrolled, progressive fibrosis leads to organ dysfunction and failure, and potentially death. In the U.S., many millions of Americans are afflicted with a fibrosis-related disease, which may affect organs including the kidney, liver, lungs, skin, and eye. Blade has assembled scientific and leadership teams with unparalleled experience. Our scientific team as well as our Board have extensive expertise in fibrosis and the discovery and development of anti-fibrotic drugs. Blade’s scientific advisory board includes world renowned experts in the pathobiology of fibrotic disease.

Events